Skip to content
Reipet – Lifestyle
Author:
Climb Bio, Inc.
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
April 7, 2026
←
Previous Page
1
2